Doxorubicin Conjugation to Reovirus Improves Oncolytic Efficacy in Triple-Negative Breast Cancer

Breast cancer is the second leading cause of cancer-related deaths in women in the United States. The triple-negative breast cancer (TNBC) subtype associates with higher rates of relapse, shorter overall survival, and aggressive metastatic disease. Hormone therapy is ineffective against TNBC, leavin...

Descripción completa

Detalles Bibliográficos
Autores principales: Berry, Jameson T.L., Muñoz, Luis E., Rodríguez Stewart, Roxana M., Selvaraj, Periasamy, Mainou, Bernardo A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493048/
https://www.ncbi.nlm.nih.gov/pubmed/32995480
http://dx.doi.org/10.1016/j.omto.2020.08.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493048/
https://www.ncbi.nlm.nih.gov/pubmed/32995480
http://dx.doi.org/10.1016/j.omto.2020.08.008

Ejemplares similares